| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8630327 | Diabetes Research and Clinical Practice | 2018 | 15 Pages |
Abstract
Diabetic patients receiving statin or ACE inhibitor/ARB therapy had higher protein C levels. Use of statin and ACE inhibitor/ARB therapy in diabetic patients decrease hypercoagulability and therefore could reduce the occurrence of cardiovascular events.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Åerife AktaÅ, Sema Uçak, Fatma Kurt, Mehmet TaÅdemir, Orkide Kutlu, Pınar Eker,